Clinical trial Recruiting at 1 site Interventional Ages 3 to 17

EOI block to reduce pain during pediatric laparoscopic gastrostomy

Official title: Effect of Ultrasound-guided External Oblique Intercostal Fascial Plane Block in Pediatric Patients Undergoing Laparoscopic Gastrostomy: A Prospective Randomized Controlled Trial

Run by Seoul National University Hospital · NCT07119346 · Data updated 2026-11-12

This trial will test whether an ultrasound-guided external oblique intercostal (EOI) block with ropivacaine reduces pain during and after laparoscopic gastrostomy in children aged 3 to 18.

More Gastrostomy trials

Quick facts

Study typeInterventional
Ages3 Years to 17 Years
SexAll
Enrollment40 (estimated)
SponsorSeoul National University Hospital
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedAugust 2025
Main results expectedMay 2028
Study endsMay 2028
Registry record updatedAugust 13, 2025
Trial IDNCT07119346 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 3 to 18 scheduled for laparoscopic gastrostomy at Seoul National University Children's Hospital with stable vital signs and no contraindication to ropivacaine or opioids are ideal candidates.

Probably not a fit

Patients with unstable vital signs, severe hepatic or renal dysfunction, known allergy to local anesthetics or opioids, or other contraindications are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll 40 children aged 3–18 undergoing laparoscopic gastrostomy under general anesthesia and randomly assign them to bilateral ultrasound-guided EOI block with 0.25% ropivacaine or a sham block with saline. The primary outcome is percent change in heart rate at surgical incision as a proxy for intraoperative nociception. Secondary outcomes include intraoperative fentanyl consumption, perioperative analgesic requirements, postoperative pain scores (r-FLACC and Pediatric Pain Profile), Analgesia Nociception Index values, and analgesia-related adverse events. The trial is conducted at Seoul National University Children's Hospital and includes perioperative monitoring and follow-up for analgesic outcomes.

Why it matters

Potential benefit: If successful, the EOI block could lower intra- and postoperative pain and reduce opioid requirements for children having laparoscopic gastrostomy.

How similar studies have gone: Abdominal wall plane blocks have shown analgesic and opioid-sparing benefits in adult and some pediatric surgeries, but the ultrasound-guided EOI block is relatively novel and pediatric evidence remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Scheduled for laparoscopic gastrostomy at Seoul National University Children's Hospital

Age ≥3 and \<18 years

Exclusion Criteria:

* Unstable vital signs

Contraindications to ropivacaine or opioids

Severe hepatic or renal dysfunction

Other investigator-determined ineligibility

Where it's running

  • Seoul National University Children's Hospital
    Seoul, South Korea
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.